Female | 148 (50.68) | 292 | 1.00c | | 1.00c | |
Male | 90 (61.22) | 147 | 1.54 (1.13 to 2.09) | 0.006 | 1.60 (1.04 to 2.48) | 0.034 |
|
Age (years) |
16–25 | 20 (54.05) | 37 | 1.00c | | 1.00c | |
26–35 | 57 (57.00) | 100 | 1.13 (0.53 to 2.37) | 0.75 | 1.45 (0.62 to 3.36) | 0.39 |
36–45 | 60 (56.60) | 106 | 1.11 (0.49 to 2.48) | 0.80 | 1.02 (0.47 to 2.21) | 0.96 |
46–55 | 57 (49.14) | 116 | 0.82 (0.37 to 1.83) | 0.63 | 0.59 (0.28 to 1.23) | 0.16 |
56–75 | 44 (55.00) | 80 | 1.04 (0.41 to 2.66) | 0.94 | 1.13 (0.46 to 2.77) | 0.79 |
|
GHQ total score, mean (SD), range | 33.11 (7.83) | 30.88d (7.65) | 1.09 (1.06 to 1.13) | <0.001 | 1.08 (1.05 to 1.12) | <0.001 |
| 14–48 | 14–48 | | | | |
|
Life-stress score |
0 | 121 (52.84) | 229 | 1.00c | | 1.00c | |
1 (mild) | 60 (56.07) | 107 | 1.14 (0.76 to 1.71) | 0.53 | 0.72 (0.43 to 1.22) | 0.22 |
2 (moderate–high) | 16 (55.17) | 29 | 1.1 (0.58 to 2.09) | 0.78 | 0.43 (0.17 to 1.09) | 0.08 |
|
Depression | 142 (71.00) | 200 | 1.00c | | 1.00c | |
|
Anxiety disorder | 66 (36.87) | 179 | 0.24 (0.14 to 0.41) | <0.001 | 0.33 (0.17 to 0.65) | <0.001 |
|
Chronic mixed anxiety and depression | 30 (50.00) | 60 | 0.41 (0.23 to 0.73) | 0.003 | 0.42 (0.23 to 0.78) | 0.006 |
|
Practice MINI score, mean (SD), rangee | 97.42 (7.67) | 97.65d (7.69) | 0.99 (0.96 to 1.02) | 0.54 | 0.98 (0.94 to 1.01) | 0.20 |
| 83.23–109.71 | 83.23–109.71 | | | | |
|
Practice type |
Intervention group | 91 (52.00) | 175 | 1.00c | | 1.00c | |
Control group | 125 (57.08) | 219 | 1.23 (0.69 to 2.18) | 0.48 | 1.23 (0.71 to 2.14) | 0.47 |
|
Trial time period |
Pre intervention | 131 (56.96) | 230 | 1.00c | | 1.00c | |
Post intervention | 107 (51.20) | 209 | 0.79 (0.58 to 1.09) | 0.16 | 0.68 (0.45 to 1.03) | 0.068 |
|
Total | 238 (54.21) | 439 | | | | |